Noriaki Moriyama

Noriaki Moriyama

Auto-generated profile, based on publicly available information

Noriaki Moriyama

Department of Cardiology, Shonan Kamakura General Hospital, Kanagawa, Japan

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
FYFutoshi Yamanaka
Futoshi Yamanaka
KSKoki Shishido
Koki Shishido
TOTomoki Ochiai
Tomoki Ochiai
NMNoriaki Moriyama
Noriaki Moriyama
KYKazumasa Yamazaki
Kazumasa Yamazaki
SSShigeru Saito
Shigeru Saito

1 February 2017 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
YTYutaka Tanaka
Yutaka Tanaka
NMNoriaki Moriyama
Noriaki Moriyama
TOTomoki Ochiai
Tomoki Ochiai
TTTakuma Takada
Takuma Takada
KTKazuki Tobita
Kazuki Tobita
SSShigeru Saito
Shigeru Saito

1 January 2014 in Circulation Journal
Verified
Journal Article
Open access
PDF file
NMNoriaki Moriyama
Noriaki Moriyama
MIMasaharu Ishihara
Masaharu Ishihara
TNTeruo Noguchi
Teruo Noguchi
MNMichio Nakanishi
Michio Nakanishi
TATetsuo Arakawa
Tetsuo Arakawa
HOHisao Ogawa
Hisao Ogawa
Background: Acute kidney injury (AKI) and acute hyperglycemia are associated with unfavorable outcomes. The impact of acute hyperglycemia on the development of AKI after acute myocardial infarction (AMI), however, remains unclear. This study was undertaken to assess the relationship between admission glucose and incidence of AKI after AMI. Methods and Results: This study consisted of 760 patients with AMI admitted to the National Cerebral and Cardiovascular Center within 48h after symptom onset. Blood sample was obtained on admission and repeated sampling was done at least every 1 or 2 days during the first week. AKI was diagnosed as increase in serum creatinine ≥0.3mg/dl or ≥50% within any 48h. Ninety-six patients (13%) had AKI during hospitalization for AMI, and these patients had higher in-hospital mortality than those without AKI (25% vs. 3%, P<0.001). Patients with AKI had higher plasma glucose (PG) on admission than those without (222±105mg/dl vs. 166±69mg/dl, P<0.001). The incidence of AKI increased as admission PG rose: 7% with PG 200mg/dl (P<0.01). On multivariate analysis admission PG was an independent predictor of AKI (odds ratio, 1.10; 95% confidence interval: 1.03–1.18, P=0.02). Conclusions: Admission hyperglycemia might have contributed to the development of AKI in patients with AMI. (Circ J 2014; 78: 1475–1480)

1 May 2018 in JACC
Verified
Journal Article
Closed access
NMNoriaki Moriyama
Noriaki Moriyama
KSKoki Shishido
Koki Shishido
YTYutaka Tanaka
Yutaka Tanaka
SYShohei Yokota
Shohei Yokota
THTakahiro Hayashi
Takahiro Hayashi
SSShigeru Saito
Shigeru Saito

7 January 2023 in The American Journal of Cardiology
Verified
Journal Article
Open access
HYHiroaki Yokoyama
Hiroaki Yokoyama
YSYoichi Sugiyama
Yoichi Sugiyama
HMHirokazu Miyashita
Hirokazu Miyashita
MJMikko Jalanko
Mikko Jalanko
TOTomoki Ochiai
Tomoki Ochiai
NMNoriaki Moriyama
Noriaki Moriyama
The impact of mild paravalvular regurgitation (PVR) after transcatheter aortic valve implantation (TAVI) remains controversial. We evaluated the impact of mild PVR after TAVI on long-term clinical outcomes. We included patients who underwent TAVI for severe symptomatic aortic stenosis between December 2008 and June 2019 at 2 international centers and compared all-cause death between the group with mild PVR (group 1) and the group with none or trace PVR (group 2). PVR was categorized using a 3-class grading scheme, and patients with PVR ≧ moderate and those who were lost to follow-up were excluded. This retrospective analysis included 1,404 patients (mean age 81.7 ± 6.5 years, 58.0% women). Three hundred fifty eight patients (25.5%) were classified into group 1 and 1,046 patients (74.5%) into group 2. At baseline, group 1 was older and had a lower body mass index, worse co-morbidities, and more severe aortic stenosis. To account for these differences, propensity score matching was performed, resulting in 332 matched pairs. Within these matched groups, during a mean follow-up of 3.2 years, group 1 had a significantly lower survival rate at 5 years (group 1: 62.0% vs group 2: 68.0%, log-rank p = 0.029, hazard ratio: 1.41 [95% confidence interval: 1.04 to 1.91]). In the matched cohort, patients with mild PVR had a significant 1.4-fold increased risk of mortality at 5 years after TAVI compared with those with none or trace PVR. Further studies with more patients are needed to evaluate the impact of longer-term outcomes.

4 December 2017 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
SSShigeru Saito
Shigeru Saito
KSKoki Shishido
Koki Shishido
NMNoriaki Moriyama
Noriaki Moriyama
TOTomoki Ochiai
Tomoki Ochiai
SMShingo Mizuno
Shingo Mizuno
MMMasato Murakami
Masato Murakami